BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 27, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 22, 2004
View Archived Issues
After Flu Vaccine Mess, Chiron's Q3 Earnings 'Almost Irrelevant'
Chiron Corp. released its third-quarter earnings Wednesday, and while those figures were better than expected, the Fluvirin disaster has faded their importance. (BioWorld Today)
Read More
MedImmune Beats Estimates, Begins CAIV-T Phase III Study
Read More
Tularik Buyout Slows Amgen; Still Beats Analysts' Estimates
Read More
Positive Phase III CTLA4-Ig Data Bump Repligen's Stock
Read More
Other News To Note
Read More